Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Lymphadenopathy, Myalgia
Clinical narrative: 2nd day Swollen lymph nodes under right arm, which was arm received shot in.; Nausea all day 2nd and 3rd day after shot; Muscle aches; Joint pain; 3rd shot Booster-bad headache & fatigue day of shot; 3rd shot Booster-bad headache & fatigue day of shot; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in right arm, administration date 26Feb2022 at 13:00 (Lot number: FK9895) at the age of 57 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Breast cancer" (unspecified if ongoing); "Blood pressure high" (unspecified if ongoing), notes: High BP; "Obesity" (unspecified if ongoing), notes: Obese; "Reaction to sulfites" (unspecified if ongoing), notes: Known allergies: Sulfites and "Latex allergy" (unspecified if ongoing), notes: Known allergies: Latex. Concomitant medications included: CITALOPRAM; ROSUVASTATIN; EXEMESTANE and LOSARTAN POTASSIUM. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: ER8727; Anatomical location: Right arm), administration date: 25Mar2021, when the patient was 56 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot number: ER8731; Anatomical location: Right arm), administration date: 15Apr2021, when the patient was 56 years old, for COVID-19 immunisation.  The following information was reported: HEADACHE (non-serious) with onset 26Feb2022, outcome "recovered" (an unknown date in 2022), described as "3rd shot Booster-bad headache & fatigue day of shot"; FATIGUE (non-serious) with onset 26Feb2022, outcome "recovered" (an unknown date in 2022), described as "3rd shot Booster-bad headache & fatigue day of shot"; LYMPHADENOPATHY (non-serious) with onset 27Feb2022 at 13:00, outcome "recovered" (an unknown date in 2022), described as " 2nd day Swollen lymph nodes under right arm, which was arm received shot in"; NAUSEA (non-serious) with onset 27Feb2022 at 13:00, outcome "recovered" (an unknown date in 2022), described as "Nausea all day 2nd and 3rd day after shot"; MYALGIA (non-serious) with onset 27Feb2022 at 13:00, outcome "recovered" (an unknown date in 2022), described as "Muscle aches"; ARTHRALGIA (non-serious) with onset 27Feb2022 at 13:00, outcome "recovered" (an unknown date in 2022), described as "Joint pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, fatigue, lymphadenopathy, nausea, myalgia and arthralgia.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient reported that she had breast cancer 7 years ago on left side. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19 and the result was negative.  No follow-up attempts are possible. No further information is expected.